Insider at

04

Insider transactions

05
0 buys (P) 4 sells (S) Net: $-27,128 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 22, 2026 ABOS S 10b5-1 895 $1.82 $1,629 255,371 Direct -0.35% Disposed 12.1% (price as of 2026-10-02)
Jan. 21, 2026 ABOS S 10b5-1 2,331 $1.80 $4,196 256,266 Direct -0.90% Disposed 13.3% (price as of 2026-10-02)
Jan. 6, 2026 ABOS S 10b5-1 6,834 $1.97 $13,463 159,464 Direct -4.11% Disposed 3.6% (price as of 2026-10-02)
Jan. 5, 2026 ABOS S 10b5-1 4,000 $1.96 $7,840 166,298 Direct -2.35% Disposed 4.1% (price as of 2026-10-02)
Jan. 21, 2025 ABOS S 10b5-1 3,219 $1.59 $5,118 170,298 Direct -1.86% Disposed 28.3% (price as of 2026-10-02)
Jan. 3, 2025 ABOS S 10b5-1 10,859 $1.85 $20,089 106,717 Direct -9.24% Disposed 10.3% (price as of 2026-10-02)
Jan. 18, 2024 ABOS S 10b5-1 3,124 $3.71 $11,590 117,576 Direct -2.59% Disposed -45.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 16, 2026 ABOS Employee Stock Option (right to buy) Common Stock (148,700) $1.89 Jan. 16, 2036 148,700 Acquired
Jan. 6, 2025 ABOS Employee Stock Option (right to buy) Common Stock (100,300) $1.85 Jan. 6, 2035 100,300 Acquired
Jan. 2, 2024 ABOS Employee Stock Option (right to buy) Common Stock (141,000) $4.23 Jan. 1, 2034 141,000 Acquired
Jan. 17, 2023 ABOS Employee Stock Option (right to buy) Common Stock (120,200) $6.11 Jan. 16, 2033 120,200 Acquired
Jan. 19, 2022 ABOS Employee Stock Option (right to buy) Common Stock (90,000) $5.19 Jan. 19, 2032 90,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 30, 2021 ABOS Stock Option (Right to Buy)→ Common Stock (186,800) 186,800 Direct
June 30, 2021 ABOS Stock Option (Right to Buy)→ Common Stock (310,989) 310,989 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ABOS

M.D. Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $336,159 · · · $124,283 · $200 $637,906
2020 $180,000 $57,600 · · · · · $237,600

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.